FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

785959000: Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)


Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3769837014 Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core
3769838016 Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet en Synonym Active Case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet Has presentation strength numerator unit mg true Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet Has unit of presentation Tablet true Inferred relationship Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet Has presentation strength denominator value 1 false Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet Has manufactured dose form Orodispersible tablet true Inferred relationship Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet Has presentation strength denominator value 1 false Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet Count of base of active ingredient 2 false Inferred relationship Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet Has presentation strength numerator unit mg true Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet Is a Carbidopa and levodopa only product in oromucosal dose form false Inferred relationship Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet Has presentation strength numerator value 100 false Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet Has BoSS Levodopa true Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet Has precise active ingredient Carbidopa true Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet Has BoSS Carbidopa anhydrous true Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet Has presentation strength numerator value 25 false Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet Has precise active ingredient Levodopa true Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet Plays role Antiparkinson therapeutic role true Inferred relationship Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet Is a Carbidopa and levodopa only product in oral dose form true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start